Henrik Bjork Hansen,Morten Grunnet,Bo Hjorth Bentzen,Lars Hyveled-Nielsen,Jorgen Buus Lassen,Claus Sundgreen
申请号：
US15906350
公开号：
US20180185304A1
申请日:
2018.02.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective combination of Tesofensine and Metoprolol for preventing the cardiovascular side effects of Tesofensine, while leaving the robust inhibitory efficacy on food intake and body weight loss unaffected.
